Coag-Sense PT/INR Monitoring System

Description

COAG-SENSE PRO TRAINING VIDEOS

Introducing the Coag-Sense™ PT/INR Monitoring System. The first PT/INR system to directly detect clot formation representing a breakthrough in PT/INR testing design simplicity!

Two million new people start taking the oral anticoagulant drug Coumadin® (warfarin) every year to prevent blood clots, heart attacks and stroke. Correct dosing of Coumadin is determined for each patient by periodically measuring blood clotting time using the prothrombin time (PT) test. The simplicity of the new Coag-Sense system offers clinicians not only the performance they require but also the reliability they demand. With the recent expansion in Medicare coverage,

Main office:

COAG-SENSE 48377 Fremont Blvd., Suite 113, Fremont, CA 94538

Contact Information: 1-866-903-0890 (US Toll-Free), 510-270-5442 (Local & International)

General Information Email: info@coagusense.com, Technical Support Email: techsupport@coagusense.com

Our Website: www.coagusense.com